切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2021, Vol. 10 ›› Issue (06): 570 -573. doi: 10.3877/cma.j.issn.2095-3232.2021.06.008

临床研究

保留肝右动脉的缩小右半肝切除术治疗肝硬化肝癌
陈骋1, 郑进方1,(), 陈劲松1, 刘俊1   
  1. 1. 570311 海口,海南省人民医院肝胆胰外科
  • 收稿日期:2021-07-22 出版日期:2021-09-23
  • 通信作者: 郑进方
  • 基金资助:
    海南省高等学校科学研究项目(Hnky2019-53)

Reduced right hepatectomy with reserved right hepatic artery for hepatocellular carcinoma complicated with liver cirrhosis

Cheng Chen1, Jinfang Zheng1,(), Jinsong Chen1, Jun Liu1   

  1. 1. Department of Hepatobiliary and Pancreatic Surgery, Hainan General Hospital, Haikou 570311, China
  • Received:2021-07-22 Published:2021-09-23
  • Corresponding author: Jinfang Zheng
目的

探讨保留肝右动脉的缩小右半肝切除术治疗肝硬化肝细胞癌(肝癌)患者的安全性和疗效。

方法

回顾性分析2018年7月至2019年4月海南省人民医院行保留肝右动脉的缩小右半肝切除术的8例肝硬化肝癌患者临床资料。患者均签署知情同意书,符合医学伦理学规定。其中男7例,女1例;平均年龄(51±8)岁。术前采用三维重建软件测算全肝体积、残肝体积。分离、结扎门静脉右支,保留肝右动脉,沿左右肝缺血分界线右移1 cm切除右半肝,保留部分肝组织。观察患者围手术期情况。

结果

术前采用三维重建软件模拟右半肝切除,标准肝体积为(993±64)ml,标准右半肝切除的残肝体积为(348±32)ml,占标准肝体积的(35.0±2.3)%;切除平面右移1 cm后残肝体积为(428±34)ml,占标准肝体积的(42.7±1.4)%。所有患者均顺利完成保留肝右动脉的缩小右半肝切除术,术中未发生与操作有关的并发症,保留的肝组织颜色红润。手术时间(224±43)min,术中出血量(220±52)ml。术后肝功能指标呈一过性升高,随后出现下降,术后7 d基本恢复正常。术后腹腔引流液较少,均于术后6 d内拔除腹腔引流管。无发生小肝综合征及肝衰竭。

结论

保留肝右动脉的缩小右半肝切除术是一种安全有效术式,对于肝硬化肝癌的患者可能是一种新的术式选择,其有利于保留更多肝组织,预防术后肝衰竭。

Objective

To evaluate the safety and efficacy of reduced right hepatectomy with reserved right hepatic artery in the treatment of hepatocellular carcinoma (HCC) complicated with liver cirrhosis.

Methods

Clinical data of 8 HCC patients complicated with liver cirrhosis who underwent reduced right hepatectomy with reserved right hepatic artery in Hainan General Hospital from July 2018 to April 2019 were retrospectively analyzed. The informed consents of all patients were obtained and the local ethical committee approval was received. Among them, 7 patients were male and 1 female, aged (51±8) years on average. The volumes of total liver and residual liver before surgery were measured by 3D reconstruction software. The right branch of the portal vein was separated and ligated. The right hepatic artery was reserved. The right liver was resected 1 cm rightwards from the ischemic line of left and right lobe, and liver tissues were partially preserved. The perioperative conditions of patients were observed.

Results

Preoperatively, 3D reconstruction software was employed to simulate the right hepatectomy. The standard liver volume was (993±64) ml. The residual liver volume after standard right hepatectomy was (348±32) ml, accounting for (35.0±2.3)% of the standard liver volume. The residual liver volume was (428±34) ml after the resection plane was shifted 1 cm to the right side, accounting for (42.7±1.4)% of the standard liver volume. The right hepatectomy with reserved right hepatic artery were successfully completed in all the patients. No intraoperative complications occurred. The preserved liver tissues were found with normal redness. The operation time was (224±43) min and intraoperative blood loss was (220±52) ml. After operation, the parameters related to liver function were increased transiently, and decreased subsequently, and basically restored to normal at postoperative 7 d. After operation, the amount of abdominal drainage was slight, and all the abdominal drainage catheters were removed within postoperative 6 d. No small-for-size syndrome or liver failure occurred.

Conclusions

Reduced right hepatectomy with reserved right hepatic artery is a safe and efficacious surgery, which probably serves as a novel surgical option for HCC patients complicated with liver cirrhosis. It can preserve more liver tissues and prevent postoperative liver failure.

图1 一例肝硬化肝癌患者行保留肝右动脉的缩小右半肝切除术前CT三维重建
表1 肝硬化肝癌患者行保留肝右动脉的缩小右半肝切除围手术期情况(±s
[1]
中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗规范(2019年版)[J].中国实用外科杂志, 2020, 40(2):121-138.
[2]
Zheng Y, Yang H, He L, et al. Reassessment of different criteria for diagnosing post-hepatectomy liver failure: a single-center study of1 683 hepatectomy[J]. Oncotarget, 2017, 8(51):89269-89277.
[3]
Sheng RF, Yang L, Jin KP, et al. Assessment of liver regeneration after associating liver partition and portal vein ligation for staged hepatectomy: a comparative study with portal vein ligation[J]. HPB, 2018, 20(4):305-312.
[4]
Pandanaboyana S, Bell R, Hidalgo E, et al. A systematic review and meta-analysis of portal vein ligation versus portal vein embolization for elective liver resection[J]. Surgery, 2015, 157(4):690-698.
[5]
Gong WF, Zhong JH, Lu Z, et al. Evaluation of liver regeneration and post-hepatectomy liver failure after hemihepatectomy in patients with hepatocellular carcinoma[J]. Biosci Rep, 2019, 39(8): BSR20190088.
[6]
Chin KM, Allen JC, Teo JY, et al. Predictors of post-hepatectomy liver failure in patients undergoing extensive liver resections for hepatocellular carcinoma[J]. Ann Hepatobiliary Pancreat Surg, 2018, 22(3):185-196.
[7]
Tustumi F, Ernani L, Coelho FF, et al. Preoperative strategies to improve resectability for hepatocellular carcinoma: a systematic review and meta-analysis[J]. HPB, 2018, 20(12):1109-1118.
[8]
Watanabe N, Yamamoto Y, Sugiura T, et al. A predictive scoring system for insufficient liver hypertrophy after preoperative portal vein embolization[J]. Surgery, 2018, 163(5):1014-1019.
[9]
Vyas S, Markar S, Partelli S, et al. Portal vein embolization and ligation for extended hepatectomy[J]. Indian J Surg Oncol, 2014, 5(1):30-42.
[10]
张东欣,姜珊,董家鸿. 大范围肝切除术后肝功能衰竭的研究进展[J].中国现代普通外科进展, 2015(4):295-299.
[11]
Kang D, Schadde E. Hypertrophy and liver function in ALPPS: correlation with morbidity and mortality[J]. Visc Med, 2017, 33(6):426-433.
[12]
Chia DKA, Yeo Z, Loh SEK, et al. ALPPS for hepatocellular carcinoma is associated with decreased liver remnant growth[J]. J Gastrointest Surg, 2018, 22(6):973-980.
[13]
Lopez-Lopez V, Robles-Campos R, Brusadin R, et al. ALPPS for hepatocarcinoma under cirrhosis: a feasible alternative to portal vein embolization[J]. Ann Transl Med, 2019, 7(22):691.
[14]
曹彦龙,李巍. ALPPS治疗剩余肝体积不足的中晚期肝癌的现状[J].中华外科杂志, 2018, 56(4):307-311.
[15]
谭凯,杜锡林,陈安等.术前基于三维可视化技术精准设计肝离断面在ALPPS中的应用[J/OL].中华肝脏外科手术学电子杂志, 2020, 9(2):158-163.
[1] 张笛, 李贞茂, 尹立雪, 周超, 雷蕾, 易诗语, 李宜蓁, 邵海玲, 张红梅. 经胸右心声学造影预估肝硬化伴食管胃底静脉曲张内镜下治疗效果的初步研究[J]. 中华医学超声杂志(电子版), 2022, 19(06): 514-520.
[2] 王莹莹, 刘莉, 吕瑞兆, 柳洁, 白晓明, 井郁陌. 下腔静脉变异度为指导的围手术期容量管理在腹腔镜肝切除术中的临床应用[J]. 中华普通外科学文献(电子版), 2022, 16(03): 194-198.
[3] 顾竹劼, 胡双双, 师小伟, 马钰, 陆敏敏, 汪建胜. 老年肝癌合并肝硬化患者围手术期不同液体管理在腹腔镜肝切除术中的对比研究[J]. 中华普通外科学文献(电子版), 2022, 16(03): 199-204.
[4] 周保富, 吴乐乐, 李永红, 胡世超. 肝切除术中不同断肝方式治疗多病灶原发性肝癌的临床效果研究[J]. 中华普通外科学文献(电子版), 2022, 16(03): 205-209.
[5] 陈一帆, 王晨晨, 卢杏生. 肝内胆管导管内乳头状瘤恶变伴门静脉及胆道变异一例并文献复习[J]. 中华肝脏外科手术学电子杂志, 2022, 11(03): 299-303.
[6] 江哲龙, 魏志鸿, 杜俊杰, 江艺, 吕立志, 杨芳. FOXC2对肝癌肝移植患者预后的影响[J]. 中华肝脏外科手术学电子杂志, 2022, 11(03): 309-314.
[7] 熊培尧, 唐雨豪, 杨子良, 朱应钦, 王骏成, 徐立. 小鼠VETC(+)肝癌模型构建及索拉非尼对VETC结构的影响[J]. 中华肝脏外科手术学电子杂志, 2022, 11(03): 315-319.
[8] 江蜜, 柴楚星, 张树华, 唐勇, 胡青钢, 万赤丹, 熊俊. 微波消融联合手术切除治疗巨大肝血管瘤一例[J]. 中华肝脏外科手术学电子杂志, 2022, 11(03): 320-322.
[9] 阙清扬, 余炯杰, 凌孙彬, 徐骁. 免疫治疗在肝癌肝移植降期治疗中的应用及前景[J]. 中华肝脏外科手术学电子杂志, 2022, 11(03): 221-224.
[10] 陈泰安, 熊永福, 徐建, 李强, 杨刚, 李敬东. 复杂肝癌腹腔镜肝切除的应用及挑战[J]. 中华肝脏外科手术学电子杂志, 2022, 11(03): 239-243.
[11] 周陈杰, 王杰钦, 张健民, 冯磊, 傅超毅, 廖晖, 徐小平, 高毅. 浅谈腹腔镜解剖性肝切除手术入路和解剖标志[J]. 中华肝脏外科手术学电子杂志, 2022, 11(03): 244-247.
[12] 苟晓雪, 王明达, 薛军, 史鸿云, 张新, 杨田. 立体定向放射治疗在肝细胞癌合并门静脉癌栓中的应用[J]. 中华肝脏外科手术学电子杂志, 2022, 11(03): 248-251.
[13] 孙克彦, 毛家玺, 刘业, 刘聪, 郭闻渊, 张磊, 滕飞. HBV相关性慢加急性肝衰竭等待肝移植患者血浆置换疗效影响因素[J]. 中华肝脏外科手术学电子杂志, 2022, 11(03): 252-257.
[14] 谢静, 毛先海, 杨建辉, 段小辉, 田朕安, 张雄, 高绪照. 再次肝切除与腹腔镜微波消融治疗复发性小肝癌临床疗效比较[J]. 中华肝脏外科手术学电子杂志, 2022, 11(03): 258-262.
[15] 赵媛媛, 张春清. 肝硬化胃静脉曲张破裂出血的治疗进展[J]. 中华消化病与影像杂志(电子版), 2022, 12(03): 162-166.
阅读次数
全文


摘要